Mediastinal lymphadenopathy describes the enlargement of lymph nodes located within the mediastinum, the central compartment of the thoracic cavity. This condition is not a specific disease itself but rather a radiological or pathological finding that signals an underlying process is occurring within the chest. The mediastinum contains vital structures such as the heart, trachea, esophagus, and major blood vessels, and the lymph nodes here play a critical role in filtering pathogens and mounting immune responses. Consequently, identifying the cause of this enlargement is essential for guiding appropriate clinical management.
Infectious Agents
Infectious processes are among the most common causes of mediastinal lymph node enlargement. Pathogens can directly invade the lymph nodes or trigger a robust immune reaction that leads to reactive hyperplasia. Specific infectious agents frequently implicated include:
Tuberculosis: Historically, tuberculosis has been a leading cause, often presenting with matted lymph nodes and associated symptoms like night sweats and weight loss.
Fungal Infections: endemic fungi such as Histoplasma capsulatum , prevalent in regions like the Ohio and Mississippi River valleys, are a classic cause.
Viral Pathogens: acute infections caused by viruses such as Epstein-Barr virus (EBV) and cytomegalovirus (CMV) can lead to diffuse lymphadenopathy, including in the mediastinum.
Malignant Conditions
Lymphomas
Malignancies originating in the lymphatic system, particularly lymphomas, are a significant concern when evaluating mediastinal lymphadenopathy. Hodgkin lymphoma frequently presents with involvement of the intrathoracic nodes, often in the young adult population. Non-Hodgkin lymphomas, including diffuse large B-cell lymphoma and certain T-cell variants, also commonly involve the mediastinal nodes. The pattern of lymph node involvement, such as symmetry or necrosis, can provide clues to the specific subtype.
Metastatic Carcinoma
Lung cancer remains the most prevalent malignant cause of mediastinal lymph node enlargement. Tumors originating in the lungs, especially squamous cell carcinoma and small cell lung cancer, frequently metastasize to regional lymph nodes. Additionally, cancers originating outside the thorax, such as breast cancer, esophageal cancer, and certain gastrointestinal malignancies, can spread to the mediastinal nodes, necessitating a thorough search for a primary site.
Autoimmune and Inflammatory Disorders
Systemic diseases characterized by chronic inflammation can also manifest as mediastinal lymphadenopathy. These conditions drive lymph node enlargement through immune complex deposition and granulomatous inflammation. Key examples include:
Sarcoidosis: This multisystem disorder is defined by the formation of non-caseating granulomas. The lungs and intrathoracic lymph nodes are frequently involved, often detected incidentally on imaging.
Rheumatoid Arthritis: Patients with long-standing rheumatoid arthritis may develop rheumatoid nodules or necrotizing lymphadenitis within the mediastinum.
Hypersensitivity Pneumonitis: Chronic antigen exposure can lead to a granulomatous reaction that involves adjacent lymph nodes.
Other Etiological Factors
The differential diagnosis for mediastinal lymphadenopathy extends beyond infection and malignancy. Several less common but important causes must be considered. Medications, particularly certain antiepileptics like phenytoin, have been associated with drug-induced lymphadenopathy. Additionally, rare conditions such as Castleman disease, a lymphoproliferative disorder, and thymic epithelial tumors can present with prominent mediastinal lymphadenopathy. Recognizing these diverse etiologies is crucial for avoiding diagnostic pitfalls.
